By Counterforce Health Team in Cerezyme (imiglucerase) —

The Complete Requirements Checklist to Get Cerezyme (Imiglucerase) Covered by Cigna in California

Answer Box: Fastest Path to Approval

Cigna covers Cerezyme (imiglucerase) for Type 1 Gaucher disease with prior authorization required. To get approved in California: (1) Your specialist must confirm diagnosis via enzyme test or genetics, document clinical symptoms, and submit PA through CoverMyMeds or fax, (2) If denied, file internal appeal within 180 days, then request California Independent Medical Review (IMR) through DMHC, (3) Start today by calling your hematologist or geneticist to gather enzyme/genetic test results and clinical documentation. Standard approval takes 5 business days; expedited review in 24 hours for urgent cases.

Table of Contents

  1. Who Should Use This Checklist
  2. Member & Plan Basics
  3. Clinical Criteria Requirements
  4. Coding & Billing Information
  5. Documentation Packet Essentials
  6. Submission Process
  7. Specialty Pharmacy Enrollment
  8. After Submission: What to Expect
  9. Common Denial Reasons & How to Fix Them
  10. Appeals Process in California
  11. Cost Assistance Options
  12. Frequently Asked Questions

Who Should Use This Checklist

This guide is for patients with Type 1 Gaucher disease and their healthcare providers seeking Cigna coverage for Cerezyme (imiglucerase) in California. You'll need this if:

  • Your doctor has prescribed Cerezyme for confirmed Type 1 Gaucher disease
  • You have Cigna insurance (commercial, Medicare Advantage, or Medicaid managed care)
  • You're facing a prior authorization requirement or coverage denial
  • You need to understand California's appeal rights and Independent Medical Review process

Expected outcome: With proper documentation meeting Cigna's clinical criteria, most medically necessary Cerezyme requests are approved. California's IMR system has historically overturned 61% of health plan denials for chronic conditions when proper evidence is submitted.

Member & Plan Basics

Coverage Requirements

  • Active Cigna Coverage: Verify your plan includes specialty drug benefits
  • Plan Type: Most Cigna plans route specialty drugs through Express Scripts/Accredo
  • Prior Authorization: Required for all Cerezyme prescriptions
  • Deductible: May apply before coverage begins; check your specific plan
Tip: Call Cigna member services at the number on your insurance card to confirm your specialty pharmacy benefits and any deductible requirements.

Clinical Criteria Requirements

Cigna requires ALL of the following criteria to be met for Cerezyme coverage:

Diagnosis Confirmation

  • Beta-glucosidase leukocyte (BGL) test showing reduced enzyme activity, OR
  • Genetic testing confirming Type 1 Gaucher disease (GBA gene mutations)
  • ICD-10 Code: E75.22 (Gaucher disease)

Age Requirement

  • Patient must be 2 years of age or older

Clinical Manifestations

Documentation of at least ONE of the following:

  • Anemia: Baseline low hemoglobin with laboratory reference range
  • Thrombocytopenia: Baseline low platelet count with laboratory reference range
  • Provider attestation of bone disease, hepatomegaly, or splenomegaly with baseline organ size documentation

Prescriber Requirement

  • Medication prescribed by or in consultation with a specialist in Gaucher disease treatment (hematologist or geneticist)

Dosing Compliance

  • Requested dose and frequency must align with FDA-approved labeling and evidence-based guidelines
  • Typical range: 2.5 U/kg three times weekly to 60 U/kg every two weeks

Coding & Billing Information

Code Type Code Description Units
HCPCS J1786 Injection, imiglucerase 1 unit = 10 units administered
ICD-10 E75.22 Gaucher disease Primary diagnosis
CPT 96365 IV infusion, initial hour Administration
CPT 96366 Each additional hour If infusion >1 hour

NDC Codes:

  • 58468-4663-xx (400-unit vial)
  • 58468-1983-xx (200-unit vial)
Note: Use JW modifier for Medicare/commercial payers when documenting discarded drug amounts from partial vials.

Documentation Packet Essentials

Provider Note Must Include:

  • Confirmed Type 1 Gaucher diagnosis with test results
  • Clinical symptoms and their severity
  • Prior treatments attempted (if any) and outcomes
  • Rationale for Cerezyme therapy
  • Dosing calculation based on patient weight
  • Treatment goals and monitoring plan

Letter of Medical Necessity Components:

  1. Patient demographics and insurance information
  2. Diagnosis confirmation with enzyme/genetic test results
  3. Clinical presentation including lab values, organ measurements
  4. Treatment rationale citing FDA labeling and clinical guidelines
  5. Dosing justification with weight-based calculations
  6. Monitoring plan for response assessment

Required Attachments:

  • Laboratory results (enzyme activity, CBC, comprehensive metabolic panel)
  • Genetic testing results (if available)
  • Imaging studies showing organ involvement (if applicable)
  • Previous treatment records (if switching from another ERT)

Submission Process

Standard Timeline: 5 Business Days

Expedited Review: 24 Hours (for urgent cases)

Submission Methods:

  1. CoverMyMeds portal (preferred)
  2. SureScripts EHR integration
  3. Fax submission to Cigna/Gateway Health (verify current fax number with plan)

Required Form Fields:

  • Patient demographics and insurance ID
  • Prescriber NPI, license number, and signature (no stamps accepted)
  • ICD-10 diagnosis code (E75.22)
  • Patient weight and height
  • Medication details: strength, directions, supply duration
  • Clinical rationale for therapy
Important: Incomplete forms are the #1 cause of delays. Double-check all required fields before submission.

Specialty Pharmacy Enrollment

Cigna typically routes Cerezyme through Accredo Specialty Pharmacy. Your prescriber will need to:

  1. Complete Accredo Prescription & Enrollment Form
  2. Fax to 888.302.1028 with insurance card copies
  3. Include all required clinical information

Patient Steps:

  • Register at MyAccredoPatients.com once prescription is received
  • Link account through myCigna app for integrated tracking
  • Schedule delivery to home or infusion site

Contact Accredo: 800-803-2523 for enrollment assistance

After Submission: What to Expect

Confirmation Process:

  1. Immediate: Receive confirmation number for submission
  2. 24-48 hours: Initial review begins
  3. 5 business days: Decision rendered (standard review)
  4. Notification: Provider and patient notified of decision

Status Tracking:

  • Check status through CoverMyMeds portal
  • Call Cigna provider services for updates
  • Monitor for requests for additional information

Record keeping: Save all confirmation numbers, correspondence, and decision letters for potential appeals.

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn
Insufficient diagnostic evidence Submit complete enzyme assay or genetic testing results with reference ranges
Prescriber not qualified Provide specialist credentials or obtain consultation letter from hematologist/geneticist
Dosing outside guidelines Include weight-based calculation and cite FDA labeling for dose justification
Missing clinical symptoms Document anemia, thrombocytopenia, or organomegaly with baseline lab values
Step therapy not completed Request override with contraindication/failure documentation or clinical rationale

Appeals Process in California

Internal Appeal (First Level)

  • Deadline: 180 days from denial
  • Process: Submit written appeal with additional clinical evidence
  • Timeline: Decision within 30 days (expedited: 72 hours for urgent)

California Independent Medical Review (IMR)

California offers robust external review rights through the Department of Managed Health Care (DMHC):

Eligibility: Denials based on "not medically necessary" or experimental/investigational determinations

Process:

  1. File online at healthhelp.ca.gov or call 888-466-2219
  2. No fee to request IMR
  3. Timeline: 45 days standard, 72 hours expedited
  4. Decision: Binding on health plan

Success Rate: California IMR historically overturns 61% of health plan denials for chronic conditions when proper medical evidence is provided.

Getting Help:

  • DMHC Help Center: 888-466-2219
  • Online portal: healthhelp.ca.gov
  • Consumer assistance: Health Consumer Alliance and legal aid organizations

For patients, families, and healthcare providers navigating complex insurance approvals for rare disease treatments, Counterforce Health offers specialized support in turning insurance denials into successful appeals. The platform helps identify denial reasons, gather appropriate clinical evidence, and draft targeted rebuttals that align with payer-specific requirements and procedural timelines.

Cost Assistance Options

Manufacturer Support:

  • Sanofi CareConnect: Copay assistance program
  • Patient assistance: For uninsured/underinsured patients

Foundation Grants:

  • National Gaucher Foundation: Financial assistance programs
  • Patient Access Network (PAN) Foundation: Copay assistance
  • HealthWell Foundation: Grant programs for rare diseases

California State Programs:

  • Medi-Cal: California's Medicaid program covers Cerezyme
  • Covered California: Marketplace plans with premium subsidies

Frequently Asked Questions

Q: How long does Cigna prior authorization take for Cerezyme in California? A: Standard review takes 5 business days. Expedited review is available in 24 hours for medically urgent cases.

Q: What if Cerezyme is non-formulary on my plan? A: Request a formulary exception with clinical documentation showing medical necessity. Your doctor must demonstrate why preferred alternatives are inappropriate.

Q: Can I request an expedited appeal in California? A: Yes, both internal appeals and IMR can be expedited if your health would be seriously jeopardized by delays in treatment.

Q: Does step therapy apply if I've been stable on Cerezyme? A: Existing therapy should generally be continued if stable. Document treatment history and clinical stability to support continuation.

Q: What happens if my internal appeal is denied? A: You can request Independent Medical Review through California DMHC within 6 months of the final internal denial.

Q: How much does Cerezyme cost without insurance? A: Cash prices typically exceed $1,700 per 400-unit vial. Monthly costs can reach $20,000+ depending on dosing, making insurance coverage essential.

Q: Can I switch from another ERT to Cerezyme? A: Yes, with proper clinical justification. Document any issues with current therapy and rationale for switching.

Q: What if I'm traveling outside California? A: Coordinate with Accredo for travel supplies and verify coverage for out-of-state administration if needed.

When insurance denials occur, having the right clinical evidence and understanding payer-specific requirements is crucial. Counterforce Health specializes in analyzing denial letters, identifying specific coverage criteria, and helping providers build compelling appeals with the exact documentation payers require for rare disease treatments like Cerezyme.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies and appeal processes may vary by plan and change over time. Always verify current requirements with your insurance plan and consult with your healthcare provider for medical decisions. For personalized assistance with insurance appeals and coverage issues, contact the California Department of Managed Health Care at 888-466-2219 or visit healthhelp.ca.gov.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.